Investigations on the mechanisms of methotrexate resistance in a cisplatin-resistant L1210 murine leukemia cell subline |
| |
Authors: | Diana H. Wroblewski Alok Bhushan Yongzhi Xuan Bradford T. Brinton Thomas R. Tritton Miles P. Hacker |
| |
Affiliation: | (1) Vermont Cancer Center and Department of Pharmacology, University of Vermont College of Medicine, Burlington, VT 05405, USA, US;(2) Department of Pharmacology, University of Vermont, Burlington, VT 05405–0068, USA, US |
| |
Abstract: | We report a murine leukemia cell variant (L1210/DDP), selected for cisplatin (DDP) resistance, to be cross-resistant to methotrexate (MTX). Cross-resistance of L1210 cells to DDP and MTX has been observed by others, and has also been recorded in P388 murine leukemia and SSC-25 human squamous carcinoma cells. We demonstrated that MTX resistance is not due to dihydrofolate reductase (DHFR) gene amplification, increased DHFR enzyme activity or decreased MTX binding to the target enzyme. Of the mechanisms commonly proposed for MTX resistance, only differences in transport were observed when comparing sensitive (L1210/0) and resistant (L1210/DDP) cells. Our results suggest that MTX resistance in L1210/DDP cells is due to altered methotrexate uptake. Received: 3 August 1994/Accepted: 14 May 1995 |
| |
Keywords: | Methotrexate Cisplatin Drug resistance |
本文献已被 SpringerLink 等数据库收录! |
|